INTRODUCTION Tumor desmoplasia, the remarkable growth of fibrotic connective tissue, is a common hallmark of pancreatic ductal adenocarcinoma (PDAC), the 4th leading cause of cancer-related mortality [1]. Recent studies clearly indicate that desmoplasia actively facilitates disease progression, metastasis, and drug resistance [2]. Precise quantification of tumor fibrosis levels in PDAC may be critically important for patient staging and for the prediction or monitoring of responses to therapy. The current gold-standard for characterizing desmoplasia-histologic analysis of biopsy samples-is invasive and cannot avoid misrepresentation by reason of sampling error. Therefore, new methods to permit noninvasive quantification of fibrosis levels in PDAC would be particularly useful. Diffusion-weighted MRI and dynamic contrast enhanced (DCE) MRI methods can detect alterations to PDAC [3, 4] but the development of quantitative imaging metrics independent of perfusion levels may be valuable for desmoplasia assessment in PDAC. Magnetization transfer (MT) MRI can be used to non-invasively probe dynamic physical processes involving the exchange of magnetization between sub-populations of free water protons and those water protons bound to tissue macromolecules [5]. MT-MRI studies have demonstrated that MT contrast (MTC) can be highly sensitive to tissue collagen concentration [6], the primary component of desmoplasia. Thus, we hypothesized that desmoplasia-associated fibrosis levels in PDAC may be directly reflected in MT-MRI magnetization transfer ratio (MTR) measurements. The purpose of this study was to compare non-invasive MTR measurements to invasive histologic assessments of tumor fibrosis-levels in three mouse xenograft models of PDAC.

